
Though the main benefit of collagen corneal crosslinking is to stop progression of keratoconus, it is not the sole benefit, said Theo Seiler, MD, PhD (Greece) here during Cornea Day at ASCRS 2016.

Though the main benefit of collagen corneal crosslinking is to stop progression of keratoconus, it is not the sole benefit, said Theo Seiler, MD, PhD (Greece) here during Cornea Day at ASCRS 2016.

Patient compliance (and non-compliance, as the case may be) is nothing new when discussing glaucoma. Nor are the multiple devices and systems previously developed or under investigation with the hope of improving compliance, said Richard Lewis, MD, speaking here at Glaucoma Day at ASCRS 2016.

Alex Huang, MD, PhD, is the winner of the Heidelberg Engineering Xtreme Research Award 2016 for his research on aqueous angiography and OCT structural analysis of outflow pathways.

Clinical researchers involved with ProgSTAR-believed to be the largest natural history study launched, to date, for Stargardt disease-are sharing interim findings during ARVO 2016.

Results from a series of preclinical studies are providing proof of principle that gene targeting using CRISPR-Cas9 genome-editing technology can prevent or treat glaucoma associated with mutations in the myocilin (MYOC) gene.

IOL implantation was associated with more inflammation and slightly more visual obscuration in 120 children age 2 or younger undergoing bilateral cataract surgery. However, the rate of glaucoma was similar compared with an aphakic group.

Patients with accommodating IOLs implanted using a femtosecond laser-assisted procedure or manual cataract removal had similar excellent visual outcomes.

For Joshua Mali, MD, the road to becoming an ophthalmologist started when he was just a teenager. When Dr. Mali was about 14 years old, his family took a trip to Nicaragua with Health for Humanity, and that was the beginning of what would be a decades-long service-oriented passion for Dr. Mali.

When the topic of IOL implantation is on the table, the age of the patient does make a difference, according to pediatric expert Courtney Kraus, MD, who spoke at the Wilmer Eye Institute’s 27th annual Current Concepts in Ophthalmology conference.

Every spring, ophthalmologists typically see a big influx of patients seeking relief from the itching and watery eyes that come with allergies. Learn the best methods to consider for helping your patients get through the allergy season.

Having a clear understanding of expectations from optical dispensary consumers is key to being able to resolve complaints.

Two clinicians explore why an optimal visual solution for patients may be using both a low-add multifocal and an extended-range-of-vision lens.

After childhood glaucoma has been treated, ophthalmologists expect to follow patients for years, monitoring them for a host of anatomical problems that can affect their vision.

Surgeons have several in-office treatments available for meibomian gland dysfunction.

Phakic IOLs are viable alternatives for treating high refractive errors.

The efficacy of a novel dry eye therapeutic may bring a valuable addition to the dry eye armamentarium with a rapid onset of action and better patient tolerability.

Implantation of the newest Implantable Collamer Lens phakic intraocular lenses (V4b and V4c) did not cause cataract formation in highly myopic patients.

For some time now, I find myself looking at my smartphone with a frequency that is frankly disconcerting. In committee meetings, lectures, sporting venues, social events, and other settings, my eyes and fingers find themselves gravitating to that little rectangular device. For some time now, I find myself looking at my smartphone with a frequency that is frankly disconcerting. In committee meetings, lectures, sporting venues, social events, and other settings, my eyes and fingers find themselves gravitating to that little rectangular device.

The advent of portable autorefractor technology may deliver autorefraction to populations that might not otherwise have any access to eye care.

Laser therapy that approaches bilateral glaucoma in a single treatment provides greater efficacy for the practice and more convenience for patients.

Giving pause to so-called conveniences that are offered for the sake of the patient may reveal just the opposite.

Cataract surgery in eyes with pseudoexfoliation syndrome is associated with increased intraoperative and postoperative risks. Strategies for improving outcomes include attention to IOL selection, and one surgeon describes why he is using a particular IOL.

A new, first-in-class, aldehyde-trap topical drop demonstrated rapid onset of action and sustained efficacy with an acceptable safety profile in a phase II clinical trial of patients with moderate-to-severe allergic conjunctivitis.

Terry Kim, MD, and Anthony Aldave, MD, refuse to let their busy worklives get in the way of pursuing their hobbies. For 7 years, they’ve found a way to merge their professional and personal lives by DJing at ophthalmology meetings.

Intraocular lenses have come a long way in the 66 years since Harold Ridley first inserted one, said Alan Carlson, MD, professor of ophthalmology, Duke University, Durham, NC.

“I am definitely telling my kids not to go into the medical field.” Given bureaucratic insurance companies and government regulations on healthcare, this type of attitude seems to represent a pervasive mindset that has started to creep into our medical community. I feel inspired to defend our profession and provide evidence that proves that being a physician is still the greatest and most rewarding job on the planet.

A hot topic in cataract surgery is alternative ways to administer perioperative medications with the goal of lowering the incidence of cystoid macular edema (CME). One way to achieve that goal would be the combination of non-steroidal anti-inflammatory drugs (NSAIDs) and transzonular steroids.

This multi-assay test shows high sensitivity and predictive value, which can help distinguish inflammatory dry eye from other types of the condition.

In the modern landscape of ophthalmology, there is an abundance of intraocular lens (IOL) calculation formulae. This often leads to a clinical dilemma when it comes to choosing the most appropriate formula.

Just like cataract surgery has evolved during my career from a three-day inpatient experience of extracapsular extraction to a three-hour outpatient experience of phaco, we physicians and our practices will need to adapt to our new reality.